Results - Announcements
Torrent Pharmaceuticals Ltd share price declined by 2.78% to Rs 4482.0 after the company's net profit eased 5.65% to Rs 534.0 crore, while revenue from operations slightly gained 1.26% to Rs 4896.0 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 26.82 lakh crore, gaining 3.59%. It has softened by 2.75% over last one week and dipped slightly by 2.21% in last one month while the market capitalization of Torrent Pharmaceuticals Ltd has eased by 1.71% and 9.63% in the same period respectively.
Profit before tax (PBT) of Torrent Pharmaceuticals Ltd stood at Rs 737.0 crore in Q3 FY26, declining 6.83% year-on-year, and rising 0.55% quarter-on-quarter. EBITDA came in at Rs 1676 crore, expanding by 50.99% YoY and remaining flat sequentially.
Total expenses saw a slight increase of 1.87% to Rs 3922.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 588.0 crore, marginally falling by 3.45% YoY, while employee benefits expense was at Rs 895.0 crore, ticking higher by 0.22% YoY.
For the TTM ended FY26, revenue from operations surged 21.53% to Rs 13753.0 crore, while net profit registered a growth of 11.88% to Rs 2138.0 crore, compared to previous TTM. EBITDA surged by 402100% to Rs 4653.0 crore, and PBT saw a minor gain of 7.44% to Rs 2872.0 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3023.0 crore in FY26, as against Rs 2585.0 crore in FY25.
Torrent Pharmaceuticals Ltd jumped 23.90% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.52% during the same period.